- Home
- ALTM vs ELAN Comparison
ALTM vs ELAN Comparison
Compare ALTM & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTM
- ELAN
- Stock Information
- Founded
- ALTM 1942
- ELAN 1954
- Country
- ALTM Ireland
- ELAN United States
- Employees
- ALTM N/A
- ELAN N/A
- Industry
- ALTM
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- ALTM
- ELAN Health Care
- Exchange
- ALTM Nasdaq
- ELAN Nasdaq
- Market Cap
- ALTM 6.2B
- ELAN 6.3B
- IPO Year
- ALTM N/A
- ELAN 2018
- Fundamental
- Price
- ALTM $5.72
- ELAN $12.03
- Analyst Decision
- ALTM Hold
- ELAN Buy
- Analyst Count
- ALTM 16
- ELAN 7
- Target Price
- ALTM $5.33
- ELAN $16.43
- AVG Volume (30 Days)
- ALTM 19.0M
- ELAN 3.8M
- Earning Date
- ALTM 02-22-2025
- ELAN 02-24-2025
- Dividend Yield
- ALTM N/A
- ELAN N/A
- EPS Growth
- ALTM N/A
- ELAN N/A
- EPS
- ALTM 0.16
- ELAN 0.41
- Revenue
- ALTM $900,600,000.00
- ELAN $4,454,000,000.00
- Revenue This Year
- ALTM $15.13
- ELAN $2.22
- Revenue Next Year
- ALTM $18.21
- ELAN $2.72
- P/E Ratio
- ALTM $36.80
- ELAN $29.13
- Revenue Growth
- ALTM N/A
- ELAN 1.99
- 52 Week Low
- ALTM $2.19
- ELAN $11.11
- 52 Week High
- ALTM $5.73
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- ALTM 70.52
- ELAN 48.98
- Support Level
- ALTM $5.66
- ELAN $11.11
- Resistance Level
- ALTM $5.73
- ELAN $12.19
- Average True Range (ATR)
- ALTM 0.06
- ELAN 0.38
- MACD
- ALTM 0.04
- ELAN 0.07
- Stochastic Oscillator
- ALTM 97.58
- ELAN 70.77
About ALTM Arcadium Lithium plc
Arcadium Lithium is a pure-play lithium producer that was formed by the Allkem-Livent merger in January 2024. The company agreed to a deal for Arcadium to be acquired by Rio Tinto in an all-cash transaction that should close in 2025. Arcadium should benefit from increased lithium demand via higher electric vehicle adoption, as lithium is a key component of EV batteries. The company's low-cost lithium carbonate production comes from two brine resources in Argentina. Arcadium also produces spodumene, a hard rock lithium upstream concentrate, from a mine in Australia and operates downstream lithium hydroxide conversion plants in the United States and China.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.